Story thread · 4 reports / 4 sources
RNA drug developer ADARx seeks $1.74 billion valuation in US IPO
reuters.com · 6h · first report
The coverage
- Drug developer ADARx seeks $1.74 billion valuation in US IPO
investing.com · 46m
- Drugmaker Adarx Pharma Seeks to Raise $371.9 Million in US IPO
bloomberg.com · 3h
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.